Cyclosporine as a biologic response modifier in the regulation of monocyte and endothelial cell procoagulant synthesis.
Carlsen
E
E
Surgical Department B, Rikshospitalet, Oslo, Norway.
Flatmark
A
A
Prydz
H
H
D003524:Cyclosporins / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D005167:Factor VII / Q000096:biosynthesis*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008222:Lymphokines / Q000494:pharmacology; D010835:Phytohemagglutinins / Q000494:pharmacology; D011994:Recombinant Proteins / Q000494:pharmacology; D013268:Stimulation, Chemical; D013925:Thromboplastin / Q000096:biosynthesis*
D003524:Cyclosporins; D008070:Lipopolysaccharides; D008222:Lymphokines; D010835:Phytohemagglutinins; D011994:Recombinant Proteins; D005167:Factor VII; D013925:Thromboplastin